alanine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Multiple Sclerosis, Relapsing-Remitting: The most common clinical variant of MULTIPLE SCLEROSIS, characterized by recurrent acute exacerbations of neurologic dysfunction followed by partial or complete recovery. Common clinical manifestations include loss of visual (see OPTIC NEURITIS), motor, sensory, or bladder function. Acute episodes of demyelination may occur at any site in the central nervous system, and commonly involve the optic nerves, spinal cord, brain stem, and cerebellum. (Adams et al., Principles of Neurology, 6th ed, pp903-914)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Messadi, A | 1 |
Fekih-Mrissa, N | 1 |
Zaouali, J | 1 |
Layouni, S | 1 |
Nsiri, B | 1 |
Yedeas, M | 1 |
Raies, A | 1 |
Mrissa, R | 1 |
Gritli, N | 1 |
Lucas, M | 1 |
Zayas, MD | 1 |
De Costa, AF | 1 |
Solano, F | 1 |
Chadli, A | 1 |
Dinca, L | 1 |
Izquierdo, G | 1 |
2 other studies available for alanine and Multiple Sclerosis, Relapsing-Remitting
Article | Year |
---|---|
[Implication of platelet-activating factor receptor A224D mutation in susceptibility to relapsing-remitting multiple sclerosis: A Tunisian population study].
Topics: Adult; Alanine; Amino Acid Substitution; Aspartic Acid; Disease Progression; Female; Genetic Associa | 2012 |
A study of promoter and intronic markers of ApoI/Fas gene and the interaction with Fas ligand in relapsing multiple sclerosis.
Topics: Adult; Alanine; Apolipoprotein L1; Apolipoproteins; Disability Evaluation; Fas Ligand Protein; fas R | 2004 |